Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

416 trials

NCT06349642
Recruiting
Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
Not applicable · United States · 3 sites
Registry update: 12 Mar 2026
NCT05665361
Recruiting
Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)
Phase 1/2 · United States · 1 site
Registry update: 16 Oct 2026
2023-505605-16-00
Recruiting
Kidney cancer
Phase 1/2 · Spain, France, Portugal, Sweden · 5 sites
Registry update: 15 Sept 2026
NCT06467097
Recruiting
Systemic Treatment Alone Versus Systemic Treatment Plus Radiotherapy in Oligometastatic Renal Cell Carcinoma
Phase 3 · South Korea · 1 site
Registry update: 20 Jun 2024
NCT06364631
Recruiting
CARE1 Pragmatic Clinical Trial
Phase 3 · Austria, Czechia, France, Netherlands · 46 sites
Registry update: 16 Jan 2025
2023-503317-29-00
Recruiting
CARE1: FIRST LINE RANDOMISED STUDY PLATFORM TO OPTIMIZE TREATMENT IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
Phase 3 · Austria, Belgium, Czechia, Germany, Denmark, Spain, Finland, France, Greece, Italy, Netherlands · 134 sites
Registry update: 28 Sept 2026
NCT06349668
Recruiting
Spinal Morphine or Intravenous Lidocaine in Robot-assisted Upper Urologic Surgery
Phase 3 · Sweden · 3 sites
Registry update: 5 Feb 2026
NCT06281678
Recruiting
A Study of IBI363 in Subjects with Advanced Solid Malignancies
Phase 2 · United States · 9 sites
Registry update: 19 Dec 2024
NCT07657325
Recruiting
Study on MRD Prediction of Efficacy of Toripalimab in the Treatment of High-risk Recurrent Renal Carcinoma
Not applicable · China · 1 site
Registry update: 18 Jun 2026
NCT06613269
Recruiting
68Ga-NY104 PET/CT Guided Radiation Therapy in CcRCC.
Phase 2 · China · 1 site
Registry update: 27 Sept 2024
NCT06321250
Recruiting
A Study of JMKX003948 Tablets in Patients With Renal Cell Carcinoma
Phase 1 · China · 1 site
Registry update: 9 Jul 2024
NCT06242470
Recruiting
A Study of MGC026 in Participants With Advanced Solid Tumors
Phase 1 · Australia, United Kingdom, United States · 12 sites
Registry update: 28 Oct 2026
NCT06715878
Recruiting
Zero Ischemia Robot-Assisted MWA Assisted Suture-less Tumor Enucleation of RCC With T1 Stage
Not applicable · China · 1 site
Registry update: 10 Dec 2024
NCT06265025
Recruiting
GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors
Phase 1/2 · South Korea · 4 sites
Registry update: 21 Mar 2024
NCT06234423
Recruiting
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
Phase 1 · Australia, Denmark, Spain, United States · 18 sites
Registry update: 14 Jan 2026
NCT06583070
Recruiting
SABR Combined With Targeted Therapy and Anti-PD-1 for Recurrent or Metastatic Renal Cancer
Not applicable · China · 2 sites
Registry update: 28 Jan 2026
NCT06290427
Recruiting
Comparison of Outcomes of Multiple Platforms for Assisted Robotic-Kidney (COMPAR-K)
Not applicable · Italy · 1 site
Registry update: 3 Jan 2025
NCT06278506
Recruiting
Resection or Ablation of Small Kidney Tumors
Not applicable · Sweden · 1 site
Registry update: 26 Feb 2024
NCT06206707
Recruiting
FMT in Checkpoint Inhibitor-mediated Diarrhea and Colitis
Not applicable · Denmark · 1 site
Registry update: 17 Nov 2025
NCT06211790
Recruiting
Proteomic Guided First-line Precision Treatment of Renal Clear Cell Carcinoma
Phase 2 · China · 1 site
Registry update: 18 Jan 2024

Ordered by registry start date. Freshness and sponsorship never change the order.